CEFIC recently launched its competitiveness study emphasizing the severity of the situation for the EU chemicals industry; over 11 million tons of capacity have already...
Galapagos, a biotechnology company headquartered in Belgium, plans to split into two entities: a newly formed company (name to be announced at a later date) that will...
Newron Pharmaceuticals, a central nervous system (CNS) focused biopharmaceutical company, and Myung In Pharm, South Korea’s leading CNS pharmaceutical company, today...
In a move to expand its oncology business, GSK is nearing a $1 billion deal to buy a US biotech developing a treatment for rare gastrointestinal tumors.
Ashland recently announced that it has signed a definitive agreement to sell its Avoca business to Mane. The transaction is expected to close in the calendar first...
Global specialty ingredients solution provider Barentz has appointed Derk Jan Terhorst as group CEO, effective Jan. 1, 2025. He will take over from Terry Hill who served...
As part of its long-term plans in the country, US drugmaker Merck & Co., operating as MSD outside of North America, has acquired WuXi Biologics’ site in Dundalk, Ireland...
